Susan D. DeVore, Director at Elevance Health, Inc. (ELV), bought 1,200 shares at $312.15 ($375K) on 2025-08-19, disclosed to the SEC on 2025-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PINC | SELL | 2017-08-31 | $1.3M | — | Filing → |
| PINC | SELL | 2017-06-14 | $1.4M | — | Filing → |
| PINC | BUY | 2013-09-27 | $405K | — | Filing → |